Exiqon Diagnostics, a division of Exiqon A/S, was a leader in personalized medicine for cancer patients. Exiqon Diagnostics was dedicated to developing and performing novel molecular and cell-based oncology assays to help physicians individualize and optimize treatment selection for their patients.
Exiqon A/S divested Exiqon Diagnostics in June 2010, resulting in the permanent closure of Exiqon Diagnostics. Subsequently, Exiqon A/S was acquired by Qiagen in 2016.
Company Details
- Founded
- -
- Address
- Tustin, California
- Industry
- Medical And Diagnostic Laboratories
- NAICS
-
Medical and Diagnostic LaboratoriesMedical LaboratoriesDiagnostic Imaging Centers
- Website
- http://www.exiqon.com
- HQ
- Tustin, California
Exiqon Diagnostics, Inc. Questions
Exiqon Diagnostics, Inc.'s website is http://www.exiqon.com
Exiqon Diagnostics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/exiqon-diagnostics-inc.
Exiqon Diagnostics, Inc.'s industry is
Medical and Diagnostic Laboratories
Exiqon Diagnostics, Inc.'s top competitors are
Genemed As,
Elabscience - India,
Wellmed Bv,
Tannaz Gostar Asia,
Hanil Scientific Inc,
Changsha Yingtai Instrument Co., Ltd,
Ovagene Oncology,
Nil Tejarat Artiman,
Genemed,
Taizhou Fanen Biotechnology Co., Ltd.
Exiqon Diagnostics, Inc.'s categories are Medical and Diagnostic Laboratories
Exiqon Diagnostics, Inc.'s founding year is 1985
